Go Back

IPET 2015 Presentations

Please note that only presentations that have been approved for sharing by their originators are available online.


Monday, 5 October 2015

Plenary Session I. PET/CT in Cancer Management

09.30–10.00 PET/CT and Molecular Imaging in Developing Countries (Henry Bom, AOFNMB)
10.00–10.30 The Burden of Cancer and the Role of Imaging Modalities (Lale Umutlu, ESR)
10.30–11.00 The Importance of PET/CT in Human Health (Homer Macapinlac, MDACC, USA)
11.00–11.30 PET/CT or PET/MR? Who Should PET Partner with? (Thomas Beyer, EFOMP)
11.30–12.00 Radiopharmaceuticals in Molecular Imaging (Philip Elsinga, Netherlands)
12.00–13.00 Lunch Break

Plenary Session II. Hybrid Imaging and Other Imaging Techniques in Breast Cancer

13.00–13.30 PET/CT Imaging in Breast Cancer (Hossein Jadvar, SNMMI)
13.30–14.00 Other Imaging Modalities in Breast Cancer (Rathan Subramaniam, ACNM, USA)
14.00–14.30 New Radiopharmaceutical Developments in Breast Cancer (Jacek Koziorowski, Sweden)
14.30–15.00 Read with the Expert: PET/CT, Breast Cancer (Andrew Ross, CANM, Canada)

Poster Review Session I

15.00–16.00 Meet-the-Authors: Poster Review (Thomas Pascual, IAEA)
Reviewers:
Henry Bom, AOFNMB
Homer Macapinlac, MDACC, USA
Hossein Jadvar, SNMMI
Rathan Subramaniam, ACNM, USA
Andrew Ross, CANM, Canada
Murat Fani Bozkurt, EANM
Helen Nadel, Canada
Sobhan Vinjamuri, BNMS, UK
Akram Al-Ibraheem, ARSNM

Plenary Session III. Theranostics and Personalized Medicine

16.00–16.30 Imaging in Personalized Medicine (Marcus Hacker, Austria)
16.30–15.00 PET/CT Imaging / Theranostics (Richard P. Baum, Germany)
17.00–17.30 Radiopharmaceutical Aspects of the Theranostics in Neuroendocrine Tumours (Vijay Kumar, ANZSNM)
17.30–18.00 Read with the Expert: Radionuclide Therapies (Richard P. Baum, Germany)

Tuesday, 6 October 2015

Plenary Session IV. Hybrid Imaging and Other Imaging Techniques in Paediatrics

09.00–09.30 The Role of PET/CT Imaging in the Management of Paediatric Cancers (Robert Howman-Giles, Australia)
09.30–10.00 Other Imaging Modalities in Paediatric Cancers (Helen Nadel, Canada)
10.00–10.30 Dose Optimization in Paediatric Patients (Madan Rehani, USA)
10.30–11.00 Read with the Expert: PET/CT, Paediatric Cancers (Robert Howman-Giles, Australia)
11.00–11.20 Coffee Break, Poster and Exhibits Viewing

Plenary Session V. Ethics, Leadership, Education and Regulatory Issues

11.20–11.40 Ethical Issues in Diagnostic Imaging Practice (Sobhan Vinjamuri, BNMS, UK)
11.40–12.00 Leadership Initiatives in Nuclear Medicine Practice (Akram Al-Ibraheem, ARSNM)
12.00–12.20 Understanding How Learners Learn: Writing Learning Objectives for Educational Activities (Thomas Pascual, IAEA)
12.20–12.35 Importance of CME Credits in the Lifelong Learning Process (Teresio Varetto, Italy)
12.35–13.00 US Production of PET Drugs for Clinical and Research Uses (Sally Schwarz, SNMMI)

Parallel Session 1a

14.00–14.40 PET/CT Imaging in Gastrointestinal Cancers (Stefano Fanti, EANM)
14.40–15.20 Other Imaging Modalities in Gastrointestinal Cancers (Gabriele Masselli, ESR)
15.20–16.00 Read with the Expert: PET/CT, Gastrointestinal Cancers (Jean Luc Urbain, CANM, Canada)

Parallel Session 1b

14.00–14.30 PET Radiopharmaceuticals Beyond FDG (Jason S. Lewis, WMIS)
14.30–15.00 Cu 64 Radiopharmaceuticals Production and Quality Control (Paola Panichelli, Italy)
15.00–15.30 Ga 68 - Radiopharmaceuticals: Current Status and Future (Frank Roesch, Germany)
15.30–16.00 Manufacturing Regulations for Imaging Radiopharmaceuticals in the United States (Orhan Suleiman, USA)

Parallel Session 1c

14.00–14.30 Need of Tracking of Patient Doses in Nuclear Medicine and Hybrid Imaging (Madan Rehani, USA)
14.30–14.50 IAEA Activities on Radiation Protection in Diagnostic Imaging (Jenia Vassileva, IAEA)
14.50–15.15 QA/QC in PET: Accreditation, Daily QC and More (Ivo Rausch, Austria)
15.15–15.40 Advances of Detector Technology in Nuclear Medicine (Satchithanantham Somanesan, SGH, Singapore)
15.40–16.00 A Consideration of the Barriers and Potential of Data-Driven PET Innovation (Adam Kesner, WFNMB)

Poster Review Session II

16.00–17.00 Meet-the-Authors: Poster Review (Thomas Pascual, IAEA)
Reviewers:
Robert Howman-Giles, Australia
Teresio Varetto, Italy
Mohamad Haidar, Lebanon
Stefano Fanti, EANM
Jean Luc Urbain, CANM, Canada
Rathan Subramaniam, ACNM, USA
Marc Seltzer, USA
Batool Al-Balooshi, ARSNM
Francesco Giammarile, France

Plenary Session VI. Special Plenary Session - Supply of Molybdenum-99

17.00–17.20 Optimization of Clinical Protocols (Kunthi Pathmaraj, WFNMB)
17.20–17.40 Status of Mo-99 Supply and New Developments (Joao A. Osso, IAEA)
17.40–18.00 Supply of Medical Radioisotopes (Kevin Charlton, Nuclear Development Division, OECD/NEA)

Wednesday, 7 October 2015

Plenary Session VII. Hybrid Imaging and Other Imaging Techniques in Lymphoma

09.00–09.25 PET/CT Imaging in Lymphoma (Ora Israel, Israel)
09.25–09.50 Other Imaging Modalities in Lymphoma (Rathan Subramaniam, ACNM, USA)
09.50–10.15 Read with the Expert: PET/CT, Lymphoma (Marc Seltzer, USA)
10.15–10.40 Radiolabeled Peptides For Imaging - What We Need to Know (Julie Sutcliffe, SRS)
10.40–11.00 Coffee Break, Poster and Exhibits Viewing

Plenary Session VIII. Hybrid Imaging and Other Imaging Techniques in Prostate Cancer

11.00–11.30 PET/CT Imaging in Prostate Cancer (Stefano Fanti, EANM)
11.30–12.00 Other Imaging Modalities in Prostate Cancer (Frederik Giesel, ESR)
12.00–12.30 Zirconium 89 and Associated Radiopharmaceuticals (Jason S. Lewis, WMIS)
12.30–13.00 Read with the Expert: PET/CT, Prostate Cancer (Stefano Fanti, EANM)
13.00–14.00 Lunch Break

Plenary Session IX. Hybrid Imaging and Other Imaging Techniques in CNS Conditions

14.00–14.20 Radiopharmaceuticals in Neurological and Psychiatric Disorders (Emilija Janevik-Ivanovska, SRS)
14.20–14.45 PET/CT Imaging in CNS Conditions (Andrew Scott, WFNMB)
14.45–15.10 Read with the Expert: PET/CT in CNS Conditions (Andrew Scott, WFNMB)
15.10–15.35 Other Imaging Modalities in CNS Conditions (Paul Parizel, ESR)
15.35–16.00 Read with the Expert: Other Imaging Modalities in CNS Conditions (Paul Parizel, ESR)

Poster Review Session III

16.00–17.00 Meet-the-Authors: Poster Review (Thomas Pascual, IAEA)
Helen Nadel, Canada
Murat Fani Bozkurt, EANM
Stefano Fanti, EANM
Frederik Giesel, ESR
Akram Al-Ibraheem, ARSNM
Andrew Scott, WFNMB
Mike Sathekge, ISORBE
Jun Hatazawa, ARCCNM
Marc Seltzer, USA

Plenary Session X. Radionuclide Therapies

17.00–17.20 Radionuclide Therapy of Prostate Cancer (Hossein Jadvar, SNMMI)
17.20–17.40 Role of Dosimetry in Radionuclide Therapies (Carlo Chiesa, Italy)
17.40–18.00 Safe Handling of Alpha Particle Emitting Pharmaceutical during Treatment of Bone Metastasis (Juergen Gay, Germany)

Thursday, 8 October 2015

Plenary Session XI. Hybrid Imaging and Other Imaging Techniques in Lung Cancer

09.00–09.25 Radiation Treatment Planning in Lung Cancer (Dietmar Georg, IOMP)
09.25–09.50 PET/CT Imaging in Lung Cancer (Homer Macapinlac, MDACC, USA)
09.50–10.15 Other Imaging Modalities in Lung Cancer (Frederik Giesel, ESR)
10.15–10.40 Read with the Expert: PET/CT, Lung Cancer (Homer Macapinlac, MDACC, USA)
10.40–11.00 Coffee Break, Poster and Exhibits Viewing

Plenary Session XII. PET/CT in Radiation Treatment Planning

11.00–11.40 Biological Target Volume Delineation with 18F-FDG PET/CT for Radiotherapy Planning (Marco Brambilla, EFOMP)
11.40–12.20 Image Derived PET Metrics in Monitoring Response to Therapy (Habib Zaidi, Switzerland)
12.20–13.00 Defining Target Volumes and Organs at Risk: A Common Language (Eduardo Rosenblatt, IAEA)
13.00–14.00 Lunch Break

Plenary Session XIII. Hybrid Imaging and Other Imaging Techniques in Head and Neck Cancer and Melanoma

14.00–14.30 PET/CT Imaging in Melanoma (Roberto Delgado-Bolton, EANM)
14.30–15.00 Read with the Expert: PET/CT, Melanoma (Roberto Delgado-Bolton, EANM)
15.00–15.30 PET/CT Imaging in Head and Neck Cancer (Ora Israel, Israel)
15.30–16.00 Read with the Expert: PET/CT, Head and Neck Cancer (Marc Seltzer, USA)

Poster Review Session IV

16.00–16.30 Meet-the-Authors: Poster Review (Thomas Pascual, IAEA)
Madan Rehani, USA
Vijay Kumar, ANZSNM
Jason S. Lewis, WMIS
S. Somanesan, Singapore
Dong Soo Lee, AOFNMB
Roberto Delgado-Bolton, EANM

Plenary Session XIV. Hybrid Imaging and Other Imaging Techniques in Infection and Inflammation

16.30–17.00 SPECT and PET Imaging in Infection and Inflammation (Mike Sathekge, ISORBE)
17.00–17.30 Optical Imaging Tools for Early Detection (Christopher Contag, WMIS)
17.30–18.00 PET/CT Imaging in Tuberculosis and HIV (Mike Sathekge, ISORBE)

Friday, 9 October 2015

Plenary Session XV. Guided Intraoperative Scintigraphy Tumour Targeting (GOSTT)

09.00–09.30 GOSTT General Concept (Francesco Giammarile, France)
09.30–10.00 GOSTT in Breast Cancer (Murat Fani Bozkurt, EANM)
10.00–10.30 GOSTT Other Relevant Applications (Francesco Giammarile, France)
10.30–11.00 Coffee Break, Poster and Exhibits Viewing

Plenary Session XVI. Multimodality Imaging - Emerging Applications and Indications

11.00–11.20 Applications of Multimodality Imaging in Cardiovascular Diseases (Henry Bom, AOFNMB)
11.20–11.50 Radionanomedicine: Beyond Multimodal Imaging to Therapy/Theranostics (Dong Soo Lee, AOFNMB)
11.50–12.20 Clinical PET in Neurology/Neurosurgery (Jun Hatazawa, ARCCNM)
12.20–12.25 Short Break

Plenary Session XVII. Closing Ceremony

12.25–13.10 Highlights & Trends (Ora Israel, Israel)
13.10–13.35 Poster Awards (Diana Paez, Joao A. Osso, IAEA)
13.35–13.50 Closing Remarks (Diana Paez, IAEA)
Shortcuts